$2.52 0.00 (0.00%) Prima Biomed Shs Sponsored American Deposit Receipt Level II Repr 100 Shs - NASDAQ

Jan. 18, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 2.52
Trade Time: Jan 18 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 2.52
Open: 2.59
Bid: 2.38
Ask: 2.69
  1. No results found.
  1. Prima BioMed Announces Granting of Patent Number US 9,244,059 Eentitled Cytotoxic Anti-LAG-3 Monoclonal Antibody and its Use in the Treatment or Prevention of Organ Transplant Rejection and Autoimmune Disease'

    Benzinga | Jan. 28, 2016 | 07:15AM EST
  2. US Patent Grants for IMP731 Antibody

    GuruFocus | Jan. 27, 2016 | 23:04PM EST
  3. Prima BioMed Initiates Phase I Melanoma Study in Australia

    GuruFocus | Jan. 26, 2016 | 23:04PM EST
  4. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 31, 2015 | 08:06AM EST
  5. Prima BioMed Initiates Phase IIb Study in Metastatic Breast Cancer

    GuruFocus | Dec. 22, 2015 | 23:04PM EST
  6. Prima BioMed Initiates Phase IIb Study in Metastatic Breast Cancer

    Benzinga | Dec. 22, 2015 | 07:11AM EST
  7. Prima BioMed Progresses Japanese Collaboration

    GuruFocus | Dec. 11, 2015 | 23:05PM EST
  8. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2015 | 08:15AM EST
  9. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 11, 2015 | 08:15AM EST
  10. Benzinga's Top Initiations

    Benzinga | Dec. 3, 2015 | 09:47AM EST
  11. Prima BioMed Raises A$2.0 Million Through Placement to Leading Australian Institution

    GuruFocus | Oct. 30, 2015 | 23:02PM EST
  12. Prima BioMed Gains Belgian Regulatory Approval to Commence a Registration Phase IIb Study of IMP321

    GuruFocus | Oct. 27, 2015 | 23:03PM EST
  13. Benzinga's Top Initiations

    Benzinga | Oct. 14, 2015 | 09:13AM EST
  14. Prima BioMed Raises A$1.55M Through Placement to Sophisticated European Healthcare Investor

    GuruFocus | Oct. 13, 2015 | 23:03PM EST
  15. UPDATE: Prima BioMed Raises A$1.55M Through Private Placement to Nyenburgh Investment Partners @A$0.05/Share

    Benzinga | Oct. 13, 2015 | 04:21AM EST
Trading Center